based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 4 analysts offering long term price targets for Rossari Biotech Ltd. An average target of ₹925.5
Source: S&P Global Market Intelligence
Rossari Biotech Ltd price forecast by 4 analysts
Upside of1.84%
High
₹950
Target
₹925.50
Low
₹885
Rossari Biotech Ltd target price ₹925.5, a slight upside of 1.84% compared to current price of ₹914.8. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Rossari Biotech Ltd revenue growth forecast
Expected growth rate Q1, FY2026:35.69%
Forecast
Actual
Including amortisation and stock based compensations
Rossari Biotech Ltd EPS growth forecast
EPS estimate Q1, FY2026:51.31%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.72 % |
3 Month Return | + 18.89 % |
1 Year Return | + 8.83 % |
Market Stats | |
Previous Close | ₹908.80 |
Open | ₹908.80 |
Volume | 1.02L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹5,024.42Cr |
P/E Ratio | 36.79 |
PEG Ratio | 7.14 |
Market Cap | ₹5,024.42 Cr |
P/B Ratio | 3.88 |
EPS | 23.66 |
Dividend Yield | 0 |
Sector | Chemicals |
ROE | 10.96 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹5,024.42 Cr | 4.51% | 0.53 | ₹130 Cr | ₹1,830 Cr | |
NA | ₹9,623.15 Cr | 49.61% | 0.56 | ₹484 Cr | ₹7,929 Cr | |
BUY | ₹20,094.22 Cr | 152.2% | 0.74 | ₹491 Cr | ₹6,419 Cr | |
HOLD | ₹5,703.55 Cr | 58.56% | 0.75 | ₹95 Cr | ₹1,752 Cr | |
₹6,351.35 Cr | 20.53% | 0.54 | ₹164 Cr | ₹2,603 Cr |
Organisation | Rossari Biotech Ltd |
Headquarters | Mumbai |
Industry | Chemicals |
E-voting on shares | Click here to vote |
Key events for Rossari Biotech Ltd
Rossari Biotech is the first stock picked by Axis Direct, with a target price of Rs 1,020 and stop loss of Rs 870. The recommended entry price ranges from Rs 888 to Rs 912.
KR Choksey Maintains Buy Rating on Rossari Biotech - 26 Jul, 2024
Rossari Biotech's Q1 revenue beat estimates due to strong volume growth in HPPC and TSC divisions. The upcoming Dahej project is expected to contribute to the top line from FY26E onwards. KR Choksey maintains a buy rating with a target price of INR 931/share, given the 15.6% upside potential.
ICICI Securities Gives Add Call on Rossari Biotech with Target Price of Rs 885 - 23 Jul, 2024
Rossari Biotech reported a consolidated total income of Rs 490.60 crore for Q1 2024, up 3.70% from the previous quarter and 18.85% YoY. The company's net profit after tax was Rs 34.69 crore. Promoters held 68.32% stake in the company as of June 30, 2024, while FIIs owned 3.83%, DIIs 16.81%. ICICI Securities has given an add call on the stock with a target price of Rs 885.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 467.29 Cr → 490.81 Cr (in ₹), with an average increase of 2.4% per quarter
Retail Holding Up
Retail Investor have increased holdings from 9.90% to 10.98% in Jun 2024 quarter
Profit Spike
Netprofit is up for the last 2 quarters, 34.13 Cr → 34.9 Cr (in ₹), with an average increase of 2.2% per quarter
Against Peers
In the last 3 years, PCBL Ltd has given 332.1% return, outperforming this stock by 368.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.32% of holdings in Jun 2024 quarter
Against Peers
In the last 1 year, PCBL Ltd has given 224.2% return, outperforming this stock by 215.4%
FII Holding Down
Foreign Institutions have decreased holdings from 4.03% to 3.83% in Jun 2024 quarter
Price Dip
In the last 3 years, ROSSARI stock has moved down by -36.1%
MF Holding Down
Mutual Funds have decreased holdings from 13.27% to 12.96% in Jun 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 68.32% | 0.00 | |
Foreign Institutions | 3.83% | ||
Mutual Funds | 12.96% | ||
Retail Investors | 10.98% | 10.89 | |
Others | 3.91% |
Rossari Biotech Ltd in the last 5 years
Lowest (28.32x)
June 4, 2024
Today (36.79x)
September 18, 2024
Industry (63.70x)
September 18, 2024
Highest (90.67x)
September 15, 2021
Rossari Biotech Ltd’s net profit jumped 19.44% since last year same period to ₹34.90Cr in the Q1 2024-2025. On a quarterly growth basis, Rossari Biotech Ltd has generated 2.26% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Rossari Biotech Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.11%.
Read More about DividendsBearish
Neutral
Bullish
Rossari Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.
Rossari Biotech Ltd (ROSSARI) share price today is ₹914.8
Rossari Biotech Ltd is listed on NSE
Rossari Biotech Ltd is listed on BSE
PE Ratio of Rossari Biotech Ltd is 36.79
PE ratio = Rossari Biotech Ltd Market price per share / Rossari Biotech Ltd Earnings per share
Today’s traded volume of Rossari Biotech Ltd(ROSSARI) is 1.02L.
Today’s market capitalisation of Rossari Biotech Ltd(ROSSARI) is ₹5024.42Cr.
Rossari Biotech Ltd(ROSSARI | Price |
---|---|
52 Week High | ₹966 |
52 Week Low | ₹656.95 |
Rossari Biotech Ltd(ROSSARI) share price is ₹914.8. It is down -5.30% from its 52 Week High price of ₹966
Rossari Biotech Ltd(ROSSARI) share price is ₹914.8. It is up 39.25% from its 52 Week Low price of ₹656.95
Rossari Biotech Ltd(ROSSARI | Returns |
---|---|
1 Day Returns | 6% |
1 Month Returns | -1.72% |
3 Month Returns | 18.89% |
1 Year Returns | 8.83% |